Besides, IL-6/JAK/STAT3 axis has also been discovered to have pleiotropic effects in cancers, including gastric cancer [20], colorectal cancer [21], and breast cancer [22], etc. However, it is not clear whether IL-6 can influence OSCC progression through JAK/STAT3 pathway. This evidence concerns the gene IL6 and breast carcinoma.